South Wales, April 6 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "WUXITECAN-2" on March 23. The details about the trademark application no. UK00004359710 published in the journal no. 2026/014 (April 3).
With Brand Murray Fuller LLP as representative, WuXi XDC Cayman Inc. filed the trademark application for the below mentioned good(s)/service(s).
Class 1 : Active chemical ingredients; active chemical ingredients for use in the
manufacture of pharmaceuticals; chemical reagents, other than for medical or
veterinary purposes; chemical substances for use in the manufacture of
pharmaceuticals; biochemical catalysts; biological preparations, other than for
medical or veterinary purposes; chemical preparations for scientific purposes,
other than for medical or veterinary use; heterocyclic compounds; chemical
substances; chemical materials and chemical preparations; antibody-drug
conjugates for use in the manufacture of pharmaceuticals; antibody-drug
conjugates other than for medical or veterinary purposes; antibody-drug
conjugates for scientific purposes.
Class 5 : Chemical pharmaceutical preparations; medicinal drugs; pharmaceutical
preparations for inhibiting tumors; pharmaceutical products for the prevention
and treatment of cancer; biological preparations for the treatment of cancer;
biological preparations for medical use; medicinal chemical preparations;
chemical reagents for medical or veterinary purposes; chemical reagents for
medical purposes; antibody-drug conjugates; antibody-drug conjugates for
pharmaceutical use; antibody-drug conjugates for the treatment of cancer;
pharmaceutical preparations containing antibody-drug conjugates.
Class 40 : Custom assembling of materials for others; Custom manufacturing of
pharmaceuticals; Custom manufacturing of drug conjugates; Customized
production service of pharmaceuticals; Customized production service of biological preparations; Custom manufacturing of Antibody-drug Conjugates;
Processing or treating of chemical reagents; Pharmaceutical processing;
Processing of biomedical preparations; Processing of drug conjugates;
Processing of antibody drugs; Custom manufacturing of antibody drugs;
Processing of biotechnology drug.
Class 42 : Development of products for others; Drug development service; Research and
development of new products; Biochemical research and development; Custom
design and development of chemical reagent antibodies and conjugate
antibodies; Research and development in the field of pharmaceutical
biomedicine and biotechnology, especially the research of antibodies including
conjugated antibodies; Biomedical research service; Development of
pharmaceutical preparations and medicines; Research and development of
Antibody-drug Conjugates; Research and development of drug conjugates;
Preclinical research and evaluation of new drugs; Consulting services in the field
of technology development; Pharmaceutical research services; Scientific
research and development; Research and development of antibodies.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004359710
Disclaimer: Curated by HT Syndication.
